Bulk preparation of micelles has the drawbacks of facile formation of large aggregates and heterogeneous particle size distribution. Microfluidic technology has shown clear potential to address these challenges for robust nanomedicine applications. In this study, docetaxel-loaded PLGA-PEG-Mal-based micelles were prepared by microfluidics and dialysis methods and their physicochemical properties were analyzed. The biological behaviors of these micelles were also investigated in the non-small cell lung cancer (NSCLC) cell line A549 in vitro as well as in vivo. Encouragingly, the mean particle size of the micelles prepared by microfluidics (DMM) was smaller, with an average size of 72 AE 1 nm and a narrow size distribution with a polydispersity index (PDI) of 0.072; meanwhile, micelles prepared by the dialysis method (DMD) had larger particle sizes (range, 102 to 144 nm) and PDIs (up to 0.390). More importantly, significantly high drug loading was achieved using the microfluidic process. The IC 50 value of DMM was lower than that of DMD. Whole-body fluorescence imaging of live mice showed that DMM achieved higher accumulation in tumors compared with DMD. DMM showed superior antitumor efficacy, with a tumor inhibition rate of 91.5%. Moreover, pathological histology analysis revealed that no evident biological toxicity was caused by the micelles. In addition, Arg-Gly-Asp (RGD) was employed as a targeting agent on the basis of DMM to prepare targeting micelles, and the targeting micelles exhibited stronger cytotoxicity and obvious antitumor efficacy. In conclusion, DMM may have obvious clinical advantages for the treatment of NSCLC due to its optimized physiochemical properties. Therefore, microfluidic technology-based micelles are a promising platform as an effective drug delivery system for incorporating anticancer agents.
Introduction
Lung cancer is the leading cause of cancer death in adults aged 40 years or older and ranks second in terms of the number of new cancer cases in adults per year.
1 Non-small cell lung cancer (NSCLC) accounts for more than 85% of all lung cancer cases.
2
Although tyrosine kinase inhibitors have marked therapeutic effects, only limited patients who have EGFR mutations or ALK rearrangements can benet from these drugs. Moreover, acquired drug resistance typically occurs within 9 to 12 months. 3 To date, chemotherapy is still the rst-line therapeutic regimen, and docetaxel (DTXL) is one of the most common anticancer drugs in clinical application. However, its clinical outcomes are signicantly compromised due to a series of adverse reactions, such as bone marrow suppression, alopecia, skin reaction, nausea, vomiting, diarrhea, and liver function damage. 4 Nanomedicine-based drug-delivery systems have raised hopes of addressing these obstacles. 5 Hydrophobic drugs can be encapsulated into carriers and can be protected from degradation to prolong their circulation times. This structure can also improve the apparent solubility of drugs to increase their stability in vivo and allow for controlled release as well as targeted delivery to avoid toxicity to normal organs. [6] [7] [8] To date, a myriad of nanodrugs, including nanoparticles, micelles, and liposomes, have been investigated in preclinical trials.
9-11
Among these, micelles are generally considered to provide the most promising availability of drug delivery systems. 12 Polymeric micelles are among the most promising candidates, and a few polymeric micelles, such as NK105, NC-6300, and Genexol-PM, are being tested in phase 2 trials with positive progress.
13,14
Although polymeric micelles are attractive drug delivery vehicles, their physical properties and delivery efficiency are strongly dependent upon their formulation conditions. 15 For example, during the preparation of nanoparticles by the nanoprecipitation method, nucleation, growth, and agglomeration processes inevitably occur at the same time, resulting in high batch-to-batch variation in both the size and size distribution of the particles; this has limited their clinical translation. 16 During the bulk preparation of polymeric micelles, the mixing timescale is longer than the characteristic timescale for chains to nucleate and grow. 17, 18 This heterogeneous environment usually leads to the formation of larger and inhomogeneous micelles without sufficient biological stability. 19 In addition, it is known that the behavior of micelles within biological environments (blood circulation and passive or active targeting) greatly depends on their chemical composition and physical properties, such as size and polydispersity. 20 For example, micelles with small size and narrow polydispersity typically contribute to greater tumor penetration. 21 Furthermore, aggregation propensity during bulk preparation decreases the drug-loading efficiency and weakens the therapeutic efficacy. 22 Taken together, it is highly favorable to obtain micelles that possess the desired physicochemical properties to achieve superior cancer therapeutic efficiency. 23, 24 Microuidics is emerging in these circumstances. Microuidics is an approach in which chemical reactions can be carried out on the microscale, based on nanoscale low-dimensional structures that control the uid ow volume to picoliters or nanoliters during the reaction. 18 Compared with conventional methods, microuidics yields homogeneous micelles with required characteristics, including favorable stability, tunable nanoparticle size, narrow size distribution, and relatively high drug loading. [25] [26] [27] Microuidics has been applied in many elds over the past decade, and it has emerged as a new fabrication technology to develop robust drug delivery systems. [28] [29] [30] To the best of our knowledge, there have been few reports on microuidics-based micellar delivery systems for lung cancer research.
We conducted a comparative study of microuidic and bulk preparations to develop micellar drug formulations for in vitro and in vivo NSCLC models (Scheme 1), with the intent to optimize the properties of drug-loading micelles based on microuidic technology for potential clinical research. In addition to comparing the physicochemical properties and antitumor effects of micelles obtained from the two methods (bulk vs. microuidics), minor polypeptides such as Arg-Gly-Asp (RGD) were introduced in the microuidics process in order to tentatively explore the antitumor efficiency of micelles combined with a targeting polypeptide agent.
Materials and methods

Materials and reagents
Docetaxel was purchased from Beijing Zhongshuo Pharmaceutical Technology Development Co., Ltd. (Beijing, China). Cyclic SH-RGD (RGDfK) was purchased from GL Biochem Ltd. (Shanghai, China). Dulbecco's Modied Eagle's Medium (DMEM) and fetal bovine serum were obtained from Gibco BRL (Grand Island, NY, USA). Poly (lactide-co-glycolide)-b-poly (ethylene glycol)-maleimide (Mal-PEG-PLGA, LA : GA molar ratio: 50 : 50; M w : 5000 : 30 000) was obtained from Akina, Inc. (West Lafayette, IN, USA). Fluorescein isothiocyanate (FITC) and Chlorin e6 (Ce6) were obtained from Sigma-Aldrich (St. Louis, MO, USA). MTT, DAPI, Annexin V-FITC, and propidium iodide (PI) were purchased from Beyotime Biotechnology (Shanghai, China). All other reagents and solvents were ordered from Sinopharm Chemical Reagent Co., Ltd. (Beijing, China) and were of analytical or chromatographic grade. Balb/c nude mice (5 week-old) were purchased from SLRC Laboratory Animal Co., Ltd. (Shanghai, China). All mice were given distilled water and maintained at a temperature of 25 AE 1 C, a relative humidity of 45% AE 5%, and a 10 h/14 h light-dark cycle. This study was performed in strict accordance with the NIH guidelines for the care and use of laboratory animals (NIH Publication no. 85-23 Rev. 1985) and was approved by the Institutional Animal Care and Use Committee of Shanghai Pulmonary Hospital (Shanghai, China).
Cell culture
Human lung adenocarcinoma (A549) and Lewis lung carcinoma (3LL) cell lines were purchased from the Chinese Academy of Sciences of Shanghai Institutes for Biological Sciences Cell Resource Center (Shanghai, China). A549 and 3LL cells were grown in Dulbecco's Modied Eagle's Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and antibiotics (penicillin 100 U mL À1 and streptomycin 100 mg mL À1 ). Cells were cultured at 37 C in an incubator with 5% CO 2 .
Preparation of docetaxel micelles
Docetaxel micelles were prepared by microuidic (DMM) and dialysis (DMD) methods. PLGA-PEG-Mal (M w PEG/PLGA: 5000/ 30 000) (10 mg) and docetaxel (2 mg) were dissolved in 4 mL of acetonitrile. During the process of micelle formation, the concentration of the polymers in solution is the most important factor. The critical micelle concentration (CMC) of PLGA-PEG ranges between 10 À6 and 10 À7 M, which is 100 times lower than that of DMM. [31] [32] [33] An optimized 10 : 2 weight ratio of polymer to drug was chosen to simultaneously obtain maximized drug encapsulation and micelle stability (ESI Table 1 †). Then, the velocity of the acetonitrile phase used to dissolve PLGA-PEG-Mal and docetaxel was set at 40 mL min À1 , with the velocity of the distilled water phase set at 360 mL min À1 . The organic phase and secondary water phase velocity at a ratio of 1 : 9 could afford relatively small particles, according to our preexperiment results (ESI Table 2 †). The reaction time was set to 40 min until the acetonitrile phase was nished; then, a light blue transparent micelle solution was acquired. The solution was transferred into a dialysis bag (molecular weight cutoff (MWCO) 8000 to 14 000) and dialyzed against deionized water for 48 h to remove acetonitrile in solution. Next, the completed dialytic light blue transparent micelles were obtained. On the other hand, DMD was prepared by a dialysis method, which is a common method for micelle preparation. 34 Briey, 10 mg of PLGA-PEG-Mal (M w PEG/PLGA; 5000/30 000) and 2 mg of docetaxel were dissolved together in 4 mL acetonitrile; then, the mixed solution was dialyzed for 48 h in the reaction to form micelles (the MWCO of the dialysis bag was 100 to 500). Aer that, the solution was dialyzed again to remove acetonitrile, and the freeze-drying process was the same.
Preparation of targeting micelles based on microuidics
To obtain targeting micelles, cyclic RGDfK was attached to the surface of DMM because the maleimide group of Mal-PEG-PLGA could connect equimolar -SH groups of cyclic RGDfK in a typical Michael addition reaction. 35 In the previous step of microuidic-based micelles preparation, the acetonitrile phase was nished, which indicated that all the PLGA-PEG-Mal dissolved in the organic phase participated in the preparation process; thus, the specic amount of cyclic RGDfK was determined. Then, this mixed solution was stirred for 24 h at normal temperature with small additions of TEA (trimethylamine) and TCEP (tris(2-carboxyethyl) phosphine). Aer this process, the mixed solution was dialyzed for 48 h (the MWCO of the dialysis bag was 8000 to 14 000 and the medium was secondary water) to remove the organic solvent, free copolymers, free drugs and free RGDfK. Aerwards, the solution was lyophilized at À80 C and stored for 24 h; then, it was freeze dried (Martin Christ, ALPHA 1-4 LD plus, Germany) and stored for 12 h to obtain the solid phase. Finally, the targeting micelles were acquired and named targeting docetaxel-loaded micelles (TDMM). The cyclic RGDfK modication on the micelles was characterized by 1 H NMR spectroscopy (ESI Fig. 1 †) . As shown in the 1 H NMR spectrum, the solvent peak of CDCl 3 was found at 7.25 ppm and the peak of tetramethylsilane (TMS) was observed at 0.07 ppm (ESI Fig. 1A-C †) . The peaks at 1.45 ppm and 2.0 ppm are due to H a and H b in Mal-PEG-PLGA, respectively (ESI Fig. 1A †) . The peak at 3.57 ppm was attributed to the H c in maleimide, and the peak at 4.64 ppm was ascribed to the H f in PLGA. For RGDfK, the peaks at 1.26 ppm and 3.75 ppm were ascribed to H a and H b , respectively. The characteristic peak at 1.75 ppm was attributed to the -SH in RGDfK (ESI Fig. 1B †) . There were two characteristic peaks at 2.41 ppm and 4.27 ppm, which can be attributed to H b and H a in RGD-labelled Mal-PEG-PLGA. This indicates that the -SH group of RGDfK was added to the maleimide of Mal-PEG-PLGA.
Micelles characterization
The size distributions and zeta potentials of the micelles were determined using a Zetasizer (Nano ZS90, Malwern Instruments, Ltd., UK). Transmission electron microscopy (TEM; JEM-200CX, JEOL, Tokyo, Japan) was applied to observe the morphologies of the micelles. The drug loading and encapsulation efficiency were estimated using a high-performance liquid chromatography (HPLC) system (Waters, 2690-996, USA). The solid phase micelles were dissolved in methanol solution. The analysis process was performed on an ODS column (Diamonsil, 5 mm, 250 mm Â 4.6 mm) at 30 C. The mobile phase consisted of methanol and water (65/35, v/v).
36
The detection wavelength was set at 230 nm, and the ow rate was 1.0 mL min À1 . The calculation formulas of the docetaxel loading rate and encapsulation rate were determined previously by HPLC (ESI Fig. 2 †) . The drug loading (DL%) and encapsulation efficiency (EE%) are expressed as the following equations:
DL% ¼ Weight of docetaxel in micelles Weight of micelles containing docetaxel Â 100%
In vitro drug release studies
The drug release experiments were performed by dialysis in PBS medium containing serum protein (pH 7.4 containing 10% FBS). Specically, solutions of docetaxel, DMD and DMM were adjusted to 0.05 mg mL À1 , respectively; then, these solutions were placed in dialysis bags (MWCO ¼ 8000 Da, Greenbird Inc., Shanghai, China). Each dialysis bag was sealed and immediately immersed in dialysis medium containing 0.5% Tween 80 to improve the solubility of docetaxel; then, the system was incubated at 37 C with a shaking speed of 120 rpm. At scheduled time points, 1 mL of released sample was removed by suction and an equal volume was immediately replenished. These collected samples were later subjected to HPLC analysis.
In vitro cellular uptake
PLGA-PEG-Mal was labeled with uorescein isothiocyanate (FITC) probe in advance to afford uorescent micelles based on the reaction between the terminal hydroxyl of the copolymer and the isothiocyanate group of FITC, as previously reported. 37,38 PLGA-PEG-Mal (10 mg), FITC (2 mg), and triethylamine (200 mL) were dissolved in 5 mL N,N 0 -dimethylformamide (DMF). Then, the reaction was performed in a dark environment for 48 h at room temperature (22 C) (ESI Fig. 2A †) . The reactant solution was dialyzed against water several times to remove the free FITC (MWCO 8000 to 14 000). Finally, FITC-PLGA-PEG-Mal was collected, followed by freeze-drying, and was then used to prepare micelles in the same way: namely, FITC-probed micelles by dialysis (FMD); FITC-probed micelles by microuidics (FMM); and FITC-probed targeting micelles by microuidics (FTMM). The uorescence intensities of the three types of micelles were detected by an ultraviolet-visible (UV) spectrophotometer (LC-UV100S, Shanghai, China): 1.2 mg of the three types of micelles were dissolved in PBS medium (pH 7.4); then, equivoluminal solutions were subjected to UV detection, and the uorescence intensity curves of the three groups were uniform (ESI Fig. 2B †) , indicating the stability of FITC-PLGA-PEG-Mal. These FITC-probed micelles could be uptaken into cancer cells through endocytosis. 39, 40 Cellular uptake images were acquired via laser scanning confocal microscope (CLSM, Leica TCS SP5 II, Germany). A549 cells at 3 Â 10 4 were plated in 6-well plates for 24 h; then, 5 mg mL À1 of the three types of FITCprobed micelles (100 mL per well) were added to the cells. Aer co-incubation for 2 h, 4 h, and 6 h, respectively, the culture medium was removed. The cells were washed three times with PBS and then xed with 4% paraformaldehyde (v/v). Aer that, the cells were stained with DAPI and were washed with PBS as well. Cellular uptake images were acquired under the confocal microscope: green uorescent vesicles represented micelles; blue uorescence indicated the cell nucleus. Furthermore, the uptake efficiency was calculated by ow cytometry (BD FACSVerse, New Jersey, USA). In order to verify the targeting effects of RGDfK on avb3 integrin, the 3LL cell line with rare avb3 expression was applied as a control group. 41 Cellular uptake images were also observed at 2 h, 4 h, and 6 h, respectively, and the uptake efficiency of the micelles was studied.
Cytotoxicity studies
The cytotoxicity activities of the micelles on A549 cells and 3LL cells were evaluated by the MTT method. Briey, A549 and 3LL cells were placed at a density of 1 Â 10 4 cells per well in 96-well plates and grown for 24 hours. Then, the cells were exposed to a series of free docetaxel (DTXL), blank micelles (BM), and DMD, DMM, and targeting docetaxel micelles prepared by microuidics (DTMM) at docetaxel concentrations ranging from 1.25 nmol mL À1 to 80 nmol mL À1 (100 mL per well) for 48 h. Each treatment group contained 6 repeat wells. Aer the incubation period, the micelles were removed and the cells were treated with 10 mL of MTT solution for 4 hours. Then, the MTT solution was removed and 150 mL of dimethyl sulfoxide (DMSO) was added to each well. The absorbance intensity was measured using a BioTek microplate reader at 490 nm to record the OD value, and the entire above procedure was dened as one independent experiment. The cell viability was calculated using the following equation:
OD treated and OD control represent the absorbance of the treatment and control cells, respectively.
Detection of apoptosis
The ow cytometry assay was used to quantify apoptosis of A549 cells. Cells (1 Â 10 6 cells per chamber) were seeded into six-well plates for 24 h; each treatment group contained 3 repeat wells. DTXL, DMD, DMM, and DTMM were added at docetaxelequivalent doses of 20 mM for 72 h. Following incubation, cells were harvested using trypsinization and washed twice with PBS. According to the kit instructions, the cells were resuspended in 100 mL of binding buffer (4% paraformaldehyde); then, 5 mL of Annexin V-APC and 5 mL of PI were added. 42 The cells were incubated in the dark for 15 min at room temperature. Flow cytometry was performed to detect the results of the assay.
In vivo imaging
Biological distribution was investigated using a Night OWL LB 983 INVIVO imaging system. Drug-free chlorin e6 (Ce6)-encapsulated micelles were prepared at a Ce6 concentration of 20 mM.
43 Ce6-encapsulated micelles were dialyzed against deionized water for 48 h in dark conditions using a dialysis bag (MWCO 8000 to 14 000) to remove the organic solvent and free Ce6. A549 cells (1 Â 10 6 cells in 300 mL PBS) were injected into the mice through le subcutaneous injection. When the tumor volume reached 100 mm 3 (about three weeks later), the mice were intravenously injected through the tail vein with Ce6-encapsulated micelles fabricated by dialysis (CMD); Ce6-encapsulated micelles fabricated by microuidics (CMM); and Ce6-encapsulated targeting micelles fabricated by microuidics (CTMM), respectively (n ¼ 5). Following anesthetization, the mice were imaged pre-injection and 2, 4, 6, and 9 h aer injection of the micelles. At 9 h aer injection, further observation of micelles in tumors and other key organs (the liver, kidneys, spleen, heart, and lungs) was performed.
Diffusion and penetration behavior of micelles in tumor tissue
In order to study the permeation and maintenance effects of different micelles in tumors, uorescent slices from different treated mice were acquired. The micelles were injected into tumor-bearing nude mice through the tail vein, and each mouse was injected with an equivalent dose of 10 mg kg À1 of Ce6. Aer 9 hours, the mice were sacriced and the tumors were removed to be made into slices. Each tumor was sliced into numerous frozen sections from top to bottom. All uorescent sections were observed under a confocal laser scanning microscope to study the diffusion and penetration behavior of the micelles into the tumors. 
Western blotting
Western blotting was performed to analyze the expression level of heat shock protein 70 (HSP70) in tumor tissues aer the different treatments. Briey, tumors removed from the nude mice in the previous antitumor efficiency experiment were cut into small pieces and lysed in Radio Immunoprecipitation Assay (RIPA) buffer with a proteinase inhibitor. Then, these compounds were ground in a homogenizer until the tumor fragments disappeared in the lysate, followed by 5 minutes of centrifugation to obtain the supernatant. The protein concentrations were measured using the BCA Protein Concentration Assay Kit (Beyotime Biotechnology, Shanghai, China). Aer normalization, equal amounts of proteins were fractionated using 10% SDS-polyacrylamide gels and transferred to polyvinyllidene uoride (PVDF) membranes. Then, these membranes were washed with Tris-Buffered Saline and Tween 20 (TBST) at room temperature for 5 min. Aer being blocked in 5% BSA at room temperature for 2 h, the membranes were washed three times with TBST and incubated with the appropriate primary anti-Hsp70 antibody at dilution concentrations of 1 : 1000 in TBST-5% BSA for 12 h at 4 C. Aer washing with TBST, the membranes were incubated with goat anti-mouse IgG-horseradish peroxidase conjugates (1 : 2000 dilution) at room temperature for 2 h. Finally, the immunoblots were visualized using an enhanced chemiluminescence (ECL) advanced Western blot detection kit (Merck Millipore, Billerica, MA, USA).
Histological examination
The potential for in vivo toxicity has always been of great concern in the development of nanodrugs. To study potential changes in the organ morphology of tumor-bearing mice, histological examination was conducted aer the antitumor efficacy experiment. The main organs (heart, liver, spleen, lungs, and kidneys) of the treated mice were collected and xed in 10% formalin solution at 4 C. The tissues were then embedded in paraffin, sliced 5 to 8 microns thick, and placed onto glass slides. Subsequently, these glass slides were stained with hematoxylin and eosin (H&E) and were imaged with uo-rescence microscopy (Nikon, Tokyo, Japan).
Statistical analyses
Experimental data are expressed as the mean AE standard deviation (SD). Statistics were analyzed using SPSS 13.0 soware (SPSS Inc., Chicago, IL, USA). Group differences were determined with one-way analysis of variance (ANOVA). A P value of less than 0.05 was considered to be statistically signicant.
Results and discussion
Micelle formulation and characterization
Polymeric micelles are usually formed through the selfassembly of amphiphilic copolymers in aqueous media at the critical micelle concentration (CMC). 44 This drug delivery system comprises a spherical core-shell structure, which contains a hydrophobic inner core that can be used to solubilize or entrap hydrophobic drugs and a hydrophilic outer shell that can protect drugs from the surrounding aqueous environment and provide particles with steric stability. [45] [46] [47] In this study, poly(lactide-co-glycolic acid)-b-poly(ethylene-co-glycol)-maleimide (PLGA-PEG-Mal; LA : GA 50 : 50 M w : 30 000 : 5000) was applied due to its superior water solubility and biodegradability. In the present study, the micelles prepared by microuidics were homogeneous, with a spherical morphology (Fig. 1) . The average sizes of DMD, DMM and DTMM were 145 AE 1 nm (PDI ¼ 0.390), 72 AE 1 nm (PDI ¼ 0.072), and 78 AE 1 nm (PDI ¼ 0.064), respectively. The particle sizes and size distributions of these micelles remained stable over time (ESI Table  3 †) . Furthermore, a recent study by P. Raei et al. showed that average size of micelles using a modied emulsication solvent evaporation technique was 123.6 AE 9.5 nm, 48 which is noticeably larger than that of the micelles based on microuidics. These results indicate signicant advantages of microuidics for forming small, homogeneous particles. Encouragingly, the drug loading efficiency of DMM was found to be three-fold higher than that of DMD (11.18% vs. 4.50%) ( Table 1) . During the bulk preparation, the uidic control is decient, which causes the copolymers to aggregate rapidly; 49 therefore, the drugs will not be loaded efficiently and the drug loading efficiency is relatively low. For microuidics, because of the wellcontrolled synthesis process, the mixing timescale is shorter than the characteristic timescale; therefore, particle selfassembly occurs primarily when the solvent change is complete, and more drugs can be loaded. 18 The zeta potential (in PBS medium, pH 7.4) of these micelles was neutral (Fig. 1C) , conrming their non-ionic status.
In vitro release of docetaxel
The in vitro drug release curves of free DTXL and docetaxelloaded micelles are shown in Fig. 1D . In the rst 10 h, >80% of docetaxel was burst-released from the DTXL solution. When the majority of the docetaxel was released, the internal osmotic pressure from the dialysis bag decreased gradually and the external osmotic pressure from the dialysis medium increased gradually. When the equilibrium osmotic pressure was reached, docetaxel would not release from free DTXL. Thus, although >95% of the docetaxel was released within 24 h, complete release could not achieved. 50 Docetaxel was released much more slowly from DMD than from DTXL solution, without burst release; the release percentage of DMD was 46.12% AE 3.01% at the 48 h point, which demonstrated the solubility and delayed release characteristics of the micelles. For DMM, the release percentage was 33.03% AE 3.06% at 48 h, which is a slower rate compared with DMD. This release difference is related to the well-controlled and homogeneous mixing in microuidics, 18 which produced micelles with uniform drug distribution. Meanwhile, uidic control of the dialysis preparation is more difficult; therefore, the micelle particles may have drug-rich domains at or near the particle surface, 51, 52 and more drugs adsorbed near the surface leads to faster release from the micelle particles. 
In vitro cellular uptake
Arginine-glycine-aspartate (RGD), a minor polypeptide consisting of a triamino acid sequence, is an important ligand that specically binds to avb3. 53, 54 Integrin avb3 is specically overexpressed in numerous cancer cells and tumor endothelial cells; however, it is not expressed or rarely expressed in nontumor cells.
55 Therefore, the RGD-avb3 motif is widely studied in cancer diagnosis and treatment, 56-60 including NSCLC.
61
Many studies have proved that avb3 is highly expressed in A549 cells.
62-65 C. Khemtong et al. also designed superparamagnetic polymeric micelles encoded with RGD to target avb3-expressing A549 cells. 66 Additionally, the 3LL cell line, which does not express avb3 integrin, was applied for in vitro studies to reect the targeting effects of RGD on A549 cells. The in vitro cellular uptake of FITC-probed micelles in A549 and 3LL cells is shown in Fig. 2A and B. Aer excitation, the FITC dye in the cells showed green uorescence, while the DAPI in the cell nuclei showed blue uorescence. The green uores-cence intensities of FMM were signicantly stronger than those of FMD at 3 time points. Meanwhile, the uorescence intensities of FTMD were greater than those of FMM. The cellular uptake efficiency was examined by ow cytometry (ESI Fig. 4 †) , and the results were consistent with the uorescence images. Because micelles can be uptaken into cells through endocytosis, the size dimensions and size homogeneity of the micelle particles are considered to be key characteristics to determine the cell uptake efficiency. 67 Compared with particles of FMD, cells prefer smaller and homogeneous particles from FMM. The more enhanced uptake of FTMM into cells can be attributed to the targeting effects of cyclic RGDfK in addition to the small particle size and homogeneity. In contrast, the uorescence intensity of FTMM was as strong as that of FMM due to the absence of avb3 in 3LL, 41 and the same result was obtained using the ow cytometry assay.
Cytotoxicity studies
The MTT assay was performed to investigate the in vitro cytotoxic activities of drug-loaded micelles against A549 and 3LL cells. As shown in Fig. 3A , the blank micelles had almost no toxicity to A549 cells, demonstrating the biological safety of PLGA-PEG-Mal. The IC 50 of DMM was lower than that of DMD (26.0 mM vs. 43.5 mM, P < 0.05), indicating that DMM entered into cells more efficiently and released drugs continuously.
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The IC 50 of DTMM was slightly lower than that of DMM (19.3 mM vs. 26.0 mM, P < 0.05), indicating the targeting effect of cyclic RGD. 68, 69 Meanwhile, in the 3LL cell line, the IC 50 of DMM was also smaller than that of DMD (26.7 mM vs. 44.1 mM, P < 0.05) but was nearly identical to that of DTMM (26.7 mM vs. 26.3 mM, P < 0.05) (Fig. 3B) , indicating that the targeting effect of RGDfK was greatly decreased. This result indicates that 3LL cells do not express avb3 integrin.
Cell apoptosis detection
The apoptotic rates of A549 cells were analyzed via ow cytometry. The apoptosis rate of DMD was approximately 2-fold higher than that of DTXL (30.3% vs. 18.7%, P < 0.05). The apoptosis rate of DMM was higher than that of DMD (48.3% vs. 30.3%, P < 0.05). Treatment with DTMM increased the apoptotic cell proportion to 56.4% (Fig. 4) . These results indicate that the micelles based on microuidics induced intense apoptosis in A549 cells. 
In vivo imaging of different micelles
In vivo imaging was performed to investigate the distribution of the Ce6-encapsulated micelles in tumor-bearing nude mice. As shown in Fig. 8A , the Ce6-encapsulated micelles accumulated in the liver at 9 h, indicating that the micelles were not rapidly cleared by the mononuclear phagocyte system. 70 As shown in Fig. 5B , the uorescence intensity in tumor tissue steadily increased with time. Among the differently treated mice, the uorescence intensity of CMM was stronger than that of CMD, and CTMM showed more intensive uorescence than CMM. There were no signicant differences in the uorescence intensities of the major organs between groups (Fig. 5B) . Moreover, the penetration and maintenance effect of Ce6-encapsulated micelles into tumors was studied by uorescent slices under a confocal microscope (Fig. 6 ). For each tumor treated with micelles, 10 pathological slices were obtained from upper-le to bottom-right, which are shown as images (a-j) in Fig. 6 . The Ce6 dye in the cells showed red uorescence, while the DAPI in the cell nuclei showed blue uorescence. CMM possessed enhanced penetration and maintenance effects in tumor tissue compared with CMD, while CTMM permeated more and deeper than CMM. This result was consistent with the in vivo imaging. Therefore, micelles prepared by microuidics had powerful accumulation and greater permeation effects into tumors. Furthermore, RGDfK-labeled micelles showed stronger accumulation because of targeting effects.
Antitumor activity in tumor-bearing nude mice
The in vivo antitumor effects of micelles were studied in tumorbearing athymic nude mice. The tumor volume time curve and weight analysis are presented in Fig. 7 . The average tumor inhibition rates of DMM and DTMM were higher than those of DTXL (P < 0.05) and DMD (Fig. 7A) , indicating that the micelles prepared by microuidics were effective in tumor inhibition and regression. In the micelles-treated mice, the body weights of the DMM and DMD groups were 24.80 AE 0.81 g and 24.20 AE 0.63 g on the 32 nd day, respectively, whereas that of the control group was 22.60 AE 0.69 g; this indicates that the micelles had almost no toxicity in vivo. Moreover, the growth rates of mice in the three micelle treatment groups were all faster than those of the docetaxel group (Fig. 7B) , which may be due to the low toxicity of PLGA-PEG-Mal and the high toxicity of docetaxel. In addition, the growth rates of mouse weight in the DMM and DTMM groups were faster than that in the DMD group, revealing the better treatment efficiency of DMM and DTMM. In tumors treated with DMM and DTMM, partial or bulk necrotic cells were clearly observed over a broad area, and the number of necrotic cells was greater than that of DMD, especially for tumors treated with DTMM; this indicates the strong impact of apoptosis on cancer cells for the drug-loaded micelles based on microuidics (Fig. 7E) . In contrast, in the control group, the cancer cells were well grown, with intact cell nuclei and good differentiation. These results demonstrated that micelles based on microuidics provide highly efficient delivery of chemotherapeutic drugs for cancer treatment.
Micelles based on microuidics inhibit the expression of HSP70
The heat shock protein 70 family are highly conserved proteins that can act as molecular chaperones and transporters. HSP70 plays an important role in carcinogenesis, promotes cancer cell proliferation, invasion, and metastasis, and inhibits apoptosis. 71 HSP70 may serve as a potential prognostic biomarker and therapeutic target for cancer. 71, 72 In the present study, western blots were performed to evaluate the expression level of HSP70. Tumors treated with PBS had the highest expression levels of HSP70, whereas the lowest expression level of HPS70 was observed in the DTMM group (Fig. 8) . The expression levels of HPS70 in both the DMM and DTMM groups were lower than those in the DTXL and DMD groups (P < 0.05). These results indicate that the micelles based on microuidics have a more signicant inhibitory effect on the expression of tumor-associated proteins.
In vivo toxicity assessment
Histological analysis with H&E staining was performed to study the toxicities of free docetaxel and the micelles. As shown in Fig. 9 , aer treatment with free docetaxel, an obvious breakdown of cardiac myocytes was observed in heart tissue; there were evident ballooning degeneration and fatty changes of hepatocytes in liver tissue; in kidney tissue, the chromatin condensed and the capillary loops expanded, and the glomerulus underwent atrophy. However, no obvious abnormal pathological changes in tissues were observed in mice treated with the micelles. These results indicate that the PLGA-PEG-Malbased micelles have little toxicity to normal organs because of the good biocompatibility of PLGA-PEG-Mal and the sustained release performance of the micelles.
Conclusions
In this study, docetaxel micelles based on PLGA-PEG-Mal were developed through microuidics and a dialysis method, respectively. Compared with the micelles prepared by the dialysis method, the micelles produced by microuidics have remarkable advantages in their physical properties, such as smaller particle size, narrower size distribution, higher drug loading efficiency, and better sustained release. The micelles prepared by microuidics showed stronger effects on cancer cells and notable antitumor efficacy. Additionally, the polypeptide RGDfK was modied on the surfaces of the nanoparticles because it has potent targeting effects on cancer cells that express integrin avb3. 53 More encouragingly, PLGA-PEGMal has low toxicity as well as superior biodegradability. All these ndings demonstrate that micelles based on microuidics are a promising delivery system for incorporating multiple anticancer drugs for lung cancer treatment.
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